Tech Company Financing Transactions
Nitric BioTherapeutics Funding Round
Nitric BioTherapeutics, based in Bristol, scored $1 million from private investors.
Transaction Overview
Company Name
Announced On
11/29/2011
Transaction Type
Debt
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2 Canal's End Road 201-A
Bristol, PA 19007
USA
Bristol, PA 19007
USA
Phone
Website
Email Address
Overview
NB Therapeutics is a biopharmaceutical and medical device company focused on developing and commercializing novel and proprietary pharmacologic therapies to address opportunities in the dermatology and podiatry markets with significant unmet needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Frank McCaney
Chief Financial Officer
James Ratigan
Chief Operating Officer
Dave Pfeiffer
Chief Technical Officer
Tanya Rhodes
Browse more venture capital transactions:
Prev: 11/29/2011: Digital Reasoning venture capital transaction
Next: 11/30/2011: NewsCred venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs